Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry
PROPEL
1 other identifier
observational
1,000
1 country
10
Brief Summary
The goal of this observational registry is to assess the use and performance of Galvanize PEF technology in a real-world setting. The main questions it aims to answer are:
- PEF utilization and performance
- Monitor safety outcomes and inform future generation devices. Participants will undergo the PEF procedure and be followed per institutional standard of care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2025
Typical duration for all trials
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 28, 2023
CompletedFirst Posted
Study publicly available on registry
May 9, 2023
CompletedStudy Start
First participant enrolled
June 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
April 23, 2026
April 1, 2026
3 years
April 28, 2023
April 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Anesthesia Type Usage for PEF Procedure
Anesthesia type usage
PEF procedure
PEF Target Location
PEF procedural target location
PEF procedure
PEF Target Size
PEF target size (cm)
PEF procedure
Secondary Outcomes (2)
Incidence of SAEs
within 30 days of PEF energy delivery
Unanticipated [not listed in the Instructions for Use (IFU)] adverse events
within 30 days of PEF energy delivery
Study Arms (1)
Aliya PEF ablation
Patients will undergo PEF ablation per institutional standard of care
Interventions
Pulsed Electric Field (PEF) Ablation per institutional standard of care
Eligibility Criteria
Patients who have had or who are scheduled to have soft tissue ablated by the Galvanize PEF technology
You may qualify if:
- Subject will undergo or has undergone PEF energy delivery utilizing Galvanize technology
- Subject is expected to be available for follow-up per the enrolling physician's standard care practices
- For prospective cohort, subject has a life expectancy of at least 3 months; for retrospective cohort, subject has completed at least three months of imaging following the PEF procedure
- Signed informed consent is obtained, if required by IRB
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (10)
Banner Health
Gilbert, Arizona, 85234, United States
Eisenhower Medical Center
Rancho Mirage, California, 92270, United States
NCH Baker
Naples, Florida, 34102, United States
New York Presbyterian Langone Health
New York, New York, 10016, United States
Duke University Hospital
Durham, North Carolina, 27705, United States
Lankenau Institute for Medical Research (LIMR)
Wynnewood, Pennsylvania, 19096, United States
AnMed Health
Anderson, South Carolina, 29621, United States
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
University of Texas-Tyler
Tyler, Texas, 75708, United States
West Virginia University
Morgantown, West Virginia, 26506, United States
Study Officials
- STUDY CHAIR
William Krimsky, MD
Chief Medical Officer
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- OTHER
- Target Duration
- 24 Months
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 28, 2023
First Posted
May 9, 2023
Study Start
June 23, 2025
Primary Completion (Estimated)
June 30, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
April 23, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
No plan of data sharing